FindTrial
Sign In

Blood parameters in cervical cancer

Peripheral blood immune cell parameters in neoplastic lesions of cervix - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/09/094978
Enrollment
30
Registered
2025-09-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified

Interventions

Intervention1: Nil: Nil

Sponsors

Maulana Azad Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged more than equal to 18 years Newly diagnosed cases of neoplastic lesions of cervix, confirmed on histopathological diagnosis

Exclusion criteria

Exclusion criteria: Patients on immunosuppressive therapy. Patients with acute or chronic inflammatory disorders.

Design outcomes

Primary

MeasureTime frame
Identification of peripheral blood immune cell parameters like NLR, PLR, SIRI, SII, AISI, CRP, LDH, ALBUMIN and IL-6 in neoplastic lesions of cervixTimepoint: Baseline—

Secondary

MeasureTime frame
Comparison of peripheral blood immune cell parameters in healthy controls and neoplastic lesions of cervix Association of peripheral blood immune cell parameters with clinicopathological features like age,menstrual history,smoking,parity,grade of cervical intraepithelial lesions,size of the tumor,stage of cervical cancer,lymphovascular invasion,and metastasis in cancers of cervixTimepoint: Baseline—

Countries

India

Contacts

Public ContactDr Prerna Arora

Maulana Azad Medical College

drprernaarora27@gmail.com9999952113

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026